Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis

This publication has 12 references indexed in Scilit:

• A 12‐week, placebo‐controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis
  Allergy, 1999
• Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mg
  Clinical Drug Investigation, 1998
• Comparison of Ebastine to Cetirizine in Seasonal Allergic Rhinitis in Adults
  Annals of Allergy, Asthma & Immunology, 1996
• Ebastine
  Drugs, 1996
• Clinical Studies of the Efficacy and Tolerability of Ebastine 10 or 20mg Once Daily in the Treatment of Seasonal Allergic Rhinitis in the US
  Drugs, 1996
• Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia
  The American Journal of Cardiology, 1991
• Efficacy and Tolerability of Ebastine at Two Dose Levels in the Treatment of Seasonal Allergic Rhinitis
  Clinical Drug Investigation, 1989
• Ebastine: the effect of a new antihistamine on psychomotor performance and autonomic responses in healthy subjects.
  British Journal of Clinical Pharmacology, 1988
• Circadian and circannual rhythms of allergic rhinitis: An epidemiologic study involving chronobiologic methods
  Journal of Allergy and Clinical Immunology, 1988
• The prevalence of allergic skin test reactivity to eight common aeroallergens in the U.S. population: Results from the second National Health and Nutrition Examination Survey
  Journal of Allergy and Clinical Immunology, 1987